News and Events
Release News
PharmaPendium 2013.2 Release
Wed, 10/04/2013The content release includes the following updates:
Year-To-Date EMA and FDA approval documents statistics for 2013 (PP 2013.1 + PP 2013.2):
- 3,597 new documents
- 70,040 new pages
- 27,206 new extracted PK data observations
- 47,140 new extracted safety data observations
- 14 new drugs
FDA Approval Packages:
- 3 new drugs:
- Cabozantinib
- Ponatinib
- Tofacitinib Citrate
- 1,277 new FDA Approval Documents
- 18,865 new pages of FDA Approval Documents
FDA Advisory Committee Documents:
- 527 new documents
- 17,553 new pages
Extracted PK data observations:
- 8,844 new extracted PK data lines
Extracted Safety data observations:
- 14,333 new extracted safety data lines
Published Toxicity Database:
- 930 new safety records
AERS (post-marketing) reports:
- 127,978 new reports (2012_Q3 is added)
The new totals for PharmaPendium are:
- 1,708,983 pages of FDA Approval documents (Including FDA Classic Collection)
- 75,173 documents of FDA Approval documents (Including FDA Classic Collection)
- 4,130 drugs with data in PharmaPendium
- 1,228,016 extracted safety data lines
- 1,320,572 extracted PK data lines
- 5,259,022 AERS (post-marketing) reports
- 6,002 documents / 107,300 pages of EMA Approval documents
- 11,842 documents / 491,869 pages of FDA Advisory Committee Meeting documents
- 10,906 documents / 308,015 pages of FDA Classic Collection
